International Journal Of Ophthalmology

雜志介紹

International Journal Of Ophthalmology雜志介紹

《International Journal Of Ophthalmology》是一本以English為主的開放獲取國際優秀期刊，中文名稱國際眼科學雜志，本刊主要出版、報道醫學-OPHTHALMOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為1.9，最新CiteScore 指數為2.5。

本刊近期中國學者發表的論文主要有：

• Advances in the treatment of rhegmatogenous retinal detachment.

  Author: Liao L¹, Zhu XH¹.

• Post-miosis changes in the anterior chamber structures in primary and lens-induced secondary chronic angle-closure glaucoma.

  Author: Li M¹, Yan XQ¹, Li GY^1,2, Zhang H¹.

• Differentiation of human embryonic stem cells derived mesenchymal stem cells into corneal epithelial cells after being seeded on decellularized SMILE-derived lenticules.

  Author: Chen Y¹, Yin YW¹, Zhao Y¹, Wu XY¹, Young K², Song WT¹, Xia XB¹, Wen D¹.

• Effect of etanercept on post-traumatic proliferative vitreoretinopathy.

  Author: Chen XF^1,2, Du M¹, Wang XH¹, Yan H¹.

英文介紹

International Journal Of Ophthalmology雜志英文介紹

· International Journal of Ophthalmology-IJO (English edition) is a global ophthalmological scientific publication

and a peer-reviewed open access periodical (ISSN 2222-3959 print, ISSN 2227-4898 online).

This journal is sponsored by Chinese Medical Association Xi’an Branch and obtains guidance and support from

WHO and ICO (International Council of Ophthalmology). It has been indexed in SCIE, PubMed,

PubMed-Central, Chemical Abstracts, Scopus, EMBASE , and DOAJ. IJO JCR IF in 2017 is 1.166.

IJO was established in 2008, with editorial office in Xi’an, China. It is a monthly publication. General Scientific

Advisors include Prof. Hugh Taylor (President of ICO); Prof.Bruce Spivey (Immediate Past President of ICO);

Prof.Mark Tso (Ex-Vice President of ICO) and Prof.Daiming Fan (Academician and Vice President,

Chinese Academy of Engineering.

International Scientific Advisors include Prof. Serge Resnikoff (WHO Senior Speciatist for Prevention of

blindness), Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of

AAO/PAAO) et al.

Honorary Editors-in-Chief: Prof. Li-Xin Xie(Academician of Chinese Academy of

Engineering/Honorary President of Chinese Ophthalmological Society); Prof. Dennis Lam (President of APAO) and

Prof. Xiao-Xin Li (Ex-President of Chinese Ophthalmological Society).

Chief Editor: Prof. Xiu-Wen Hu (President of IJO Press).

Editors-in-Chief: Prof. Yan-Nian Hui (Ex-Director, Eye Institute of Chinese PLA) and

Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics).

Associate Editors-in-Chief include:

Prof. Ning-Li Wang (President Elect of APAO);

Prof. Ke Yao (President of Chinese Ophthalmological Society) ;

Prof.William Smiddy (Bascom Palmer Eye instituteUSA) ;

Prof.Joel Schuman (President of Association of University Professors of Ophthalmology,USA);

Prof.Yizhi Liu (Vice President of Chinese Ophtlalmology Society);

Prof.Yu-Sheng Wang (Director of Eye Institute of Chinese PLA);

Prof.Ling-Yun Cheng (Director of Ocular Pharmacology, Shiley Eye Center, USA).

IJO accepts contributions in English from all over the world. It includes mainly original articles and review articles,

both basic and clinical papers.

Instruction is Welcome Contribution is Welcome Citation is Welcome

Cooperation organization

International Council of Ophthalmology(ICO), PubMed, PMC, American Academy of Ophthalmology, Asia-Pacific, Thomson Reuters, The Charlesworth Group, Crossref,Scopus,Publons, DOAJ etc.